Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Establishes the prescription drug supply chain transparency act; requires pharmacy services administrative organizations, pharmacy switch companies and rebate aggregators to register with the insurance department and to provide certain disclosures relating to the ownership and activities of such entities; relates to deposits into the pharmacy benefit manager regulatory fund.
Introduced
Jan 8, 2025
Last Action
Feb 25, 2026
Session
NY 2025-2026
Sponsors
1 primary · 2 co
RETURNED TO SENATE
AMENDED ON THIRD READING 438A
VOTE RECONSIDERED - RESTORED TO THIRD READING
RECALLED FROM ASSEMBLY
DELIVERED TO ASSEMBLY
REFERRED TO INSURANCE
PASSED SENATE
ADVANCED TO THIRD READING
2ND REPORT CAL.
1ST REPORT CAL.296
REFERRED TO INSURANCE
RETURNED TO SENATE
DIED IN ASSEMBLY
PASSED SENATE
REFERRED TO INSURANCE
DELIVERED TO ASSEMBLY
ADVANCED TO THIRD READING
2ND REPORT CAL.
1ST REPORT CAL.232
REFERRED TO INSURANCE
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
AMENDED ON THIRD READING 438A